RYR1 - Ryanodine Receptor 1

RYR1 — Ryanodine Receptor 1

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Ryanodine Receptor 1</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>RYR1</td></tr>
<tr><td><strong>Full Name</strong></td><td>Ryanodine Receptor 1</td></tr>
<tr><td><strong>Chromosome</strong></td><td>19q13.2</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[6261](https://www.ncbi.nlm.nih.gov/gene/6261)</td></tr>
<tr><td><strong>OMIM</strong></td><td>180901</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000196218</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[P21810](https://www.uniprot.org/uniprot/P21810)</td></tr>
<tr><td><strong>Protein Length</strong></td><td>5,038 amino acids</td></tr>
<tr><td><strong>Expression</strong></td><td>Skeletal muscle, brain (neurons)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Central Core Disease, Malignant Hyperthermia, Alzheimer's Disease, Parkinson's Disease</td></tr>
</table>
</div>

Overview

RYR1 — Ryanodine Receptor 1

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Ryanodine Receptor 1</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>RYR1</td></tr>
<tr><td><strong>Full Name</strong></td><td>Ryanodine Receptor 1</td></tr>
<tr><td><strong>Chromosome</strong></td><td>19q13.2</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[6261](https://www.ncbi.nlm.nih.gov/gene/6261)</td></tr>
<tr><td><strong>OMIM</strong></td><td>180901</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000196218</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[P21810](https://www.uniprot.org/uniprot/P21810)</td></tr>
<tr><td><strong>Protein Length</strong></td><td>5,038 amino acids</td></tr>
<tr><td><strong>Expression</strong></td><td>Skeletal muscle, brain (neurons)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Central Core Disease, Malignant Hyperthermia, Alzheimer's Disease, Parkinson's Disease</td></tr>
</table>
</div>

Overview

RYR1 (Ryanodine Receptor 1) encodes the skeletal muscle calcium release channel, a massive intracellular ion channel responsible for triggering muscle contraction through the release of calcium from the sarcoplasmic reticulum (SR)[@fill2002]. As the largest known ion channel complex, RYR1 forms a homotetramer of approximately 2.2 MDa, serving as the primary pathway for calcium-induced calcium release (CICR) in skeletal muscle cells. The discovery and cloning of RYR1 in the 1980s revolutionized our understanding of excitation-contraction (EC) coupling and continues to inform research into muscle physiology and disease[@zorzato1985][@maciel1989].

While RYR1 is predominantly expressed in skeletal muscle, significant expression also occurs in select neuronal populations within the central nervous system, particularly in the [hippocampus](/brain-regions/hippocampus), [cerebellum](/brain-regions/cerebellum), and various cortical regions[@du2002]. Neuronal RYR1 plays crucial roles in regulating intracellular calcium dynamics, synaptic plasticity, and neuronal homeostasis. Dysregulation of neuronal RYR1 has been increasingly recognized as a contributing factor in the pathogenesis of neurodegenerative diseases, including [Alzheimer's Disease](/diseases/alzheimers-disease) (AD), [Parkinson's Disease](/diseases/parkinsons-disease) (PD), and related disorders[@bermek2021].

Structure and Mechanism

Protein Architecture

RYR1 is an enormous protein comprising 5,038 amino acids that forms a homotetrameric channel complex[@beeck2008]. Each monomer contains:

Calcium Release Mechanism

Skeletal Muscle EC Coupling:

• Voltage sensors in the T-tubule membrane (Cav1.1) detect depolarization
• Direct mechanical coupling to RYR1 triggers channel opening
• No calcium entry is required—purely mechanical signal transduction

• RYR1 can be activated by elevated intracellular calcium
• Creates positive feedback loop for calcium release
• Important in cardiac muscle (via RYR2) and some neuronal contexts

Regulation

| Regulator | Effect | Mechanism |
|-----------|--------|-----------|
| Calcium | Activation | Direct binding to activation sites |
| Mg2+ | Inhibition | Competes with Ca2+ at activation sites |
| ATP | Activation | Stabilizes open state |
| Caffeine | Activation | Lowers activation threshold |
| Reactive oxygen species | Variable | Oxidative modifications |
| Calmodulin | Biphasic | Ca2+-dependent activation/inhibition |

Expression and Cellular Localization

Brain Expression

Within the nervous system, RYR1 exhibits a selective distribution[@du2002]:

| Brain Region | Expression Level | Cell Types |
|--------------|-----------------|------------|
| Hippocampus | Moderate-High | CA1-CA3 pyramidal neurons |
| Cerebellum | High | Purkinje cells |
| Cerebral Cortex | Moderate | Layer 5 pyramidal neurons |
| Basal Ganglia | Moderate | Striatal medium spiny neurons |
| Spinal Cord | High | Motor neurons |

Subcellular Distribution

In neurons, RYR1 localizes to:

• Dendritic shafts: Distributed throughout dendritic arborization
• Synaptic spines: Concentrated at postsynaptic sites
• Somatic endoplasmic reticulum: Calcium release from internal stores
• Axon terminals: Regulates neurotransmitter release
• Mitochondrial proximity: Often near mitochondria for calcium crosstalk

Role in Neurodegenerative Diseases

Alzheimer's Disease

RYR1 dysfunction plays a significant role in AD pathogenesis through multiple mechanisms[@stutzmann2006][@mattson2008][@bermek2021]:

Calcium Dysregulation Hypothesis:
The calcium dysregulation hypothesis of AD posits that altered calcium signaling is a fundamental early event in disease pathogenesis. RYR1 contributes through:

Consequences:

• Mitochondrial dysfunction from excessive calcium uptake
• Synaptic failure from impaired calcium handling
• Tau pathology from calcium dysregulation
• Abeta oligomers directly interact with RYR1

Parkinson's Disease

In Parkinson's disease, RYR1 contributes to dopaminergic neuron vulnerability[@chen2023]:

Mechanisms of Neurodegeneration:

Therapeutic Implications:

• RYR1 antagonists protect dopaminergic neurons in models
• RYR1 modulators reduce oxidative stress

Other Neurodegenerative Conditions

RYR1 dysfunction is implicated in:

• Amyotrophic Lateral Sclerosis (ALS): Calcium dysregulation in motor neurons
• Huntington's Disease: Altered RYR1 function in medium spiny neurons
• Aging-related neurodegeneration: Progressive RYR1 dysfunction with age

Biological Functions

Excitation-Contraction Coupling

In skeletal muscle, RYR1 serves as the final effector of EC coupling:

Synaptic Plasticity

Neuronal RYR1 plays essential roles in synaptic plasticity[@gomez2019]:

Long-Term Potentiation (LTP):

• RYR1-mediated calcium release contributes to LTP induction
• Calcium from RYR1 activates CaMKII

• RYR1 contributes to LTD maintenance
• RYR1-driven calcium influences AMPA receptor internalization

Calcium Homeostasis

• ER calcium signaling
• Calcium wave propagation
• Store-operated calcium entry
• Mitochondrial calcium regulation

Interaction Network

Protein Partners

| Partner | Interaction Type | Functional Effect |
|---------|-----------------|-------------------|
| Cav1.1 (skeletal) | Mechanical coupling | EC coupling trigger |
| Calmodulin | Calcium-dependent binding | Biphasic regulation |
| FKBP12 | Stabilizing binding | Enhanced channel function |
| Calsequestrin | Calcium storage | Calcium buffering |
| Junctophilin | Structural | T-SR anchoring |
| TRPC channels | Calcium influx | Store-operated entry |

Signaling Pathways

• Calcineurin/NFAT pathway
• CaMKII signaling
• PKA signaling
• MAPK pathway
• Cell death pathways

Therapeutic Implications

Given the role of RYR1 dysregulation in neurodegeneration, therapeutic strategies include[@hernandez2021]:

Challenges:

• Blood-brain barrier penetration
• Selectivity (RYR1 vs RYR2/RYR3)
• Therapeutic window

Animal Models

Knockout Models:

• Constitutive Ryr1 knockout: embryonic lethal
• Conditional neuronal knockout: viable with memory deficits

• Human RYR1 mutations: recapitulate disease phenotypes
• Overexpression models: study gain-of-function

Genetic Considerations

Over 300 pathogenic RYR1 mutations cause:

• Malignant hyperthermia
• Central Core Disease
• Neuromalignant syndrome
• Arthrogryposis multiplex congenita

Research Directions

Clinical Trials

RYR1-Targeted Therapeutics

| Compound | Target | Phase | Status | Indication |
|----------|--------|-------|--------|------------|
| Dantrolene | RYR1 | II/III | Approved (MH) | Malignant Hyperthermia |
| Dexmedetomidine | RYR1 | II | Completed | Perioperative neuroprotection |
| S48168 | RYR1 | I | Completed | Heart failure |

RYR1 Modulators in Development

Clinical Development Status:

• Dantrolene: FDA-approved for malignant hyperthermia, being repurposed for neurodegenerative diseases
• Novel RYR1 antagonists: Several compounds in preclinical development for AD/PD
• RYR1 stabilizers: FKBP12-binding compounds in early-stage trials

• Blood-brain barrier penetration
• Selectivity for neuronal RYR1 vs. muscle RYR1
• Therapeutic window balancing efficacy and safety
• RYR1 isoform-specific targeting (RYR1 vs. RYR2/RYR3)

Biomarker Development

• RYR1 expression levels in CSF as disease progression markers
• Calcium imaging biomarkers for RYR1 dysfunction
• Genetic variants as risk stratification tools

Conclusion

RYR1 represents a critical nexus linking calcium signaling to both muscle function and neuronal health. Originally studied for its essential role in skeletal muscle contraction, RYR1 has emerged as an important player in neurodegenerative disease pathogenesis. The channel's dysfunction contributes to calcium dysregulation, mitochondrial failure, oxidative stress, and synaptic impairment—all hallmarks of AD, PD, and related disorders.

See Also

• [Calcium Signaling](/mechanisms/calcium-signaling-dysregulation)
• [Ryanodine Receptor Protein](/proteins/ryr1-protein)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Synaptic Plasticity](/mechanisms/synaptic-plasticity)
• [Hippocampus](/brain-regions/hippocampus)
• [Cerebellum](/brain-regions/cerebellum)
• [Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction)
• [Oxidative Stress](/mechanisms/oxidative-stress)

External Links

• [NCBI Gene: RYR1](https://www.ncbi.nlm.nih.gov/gene/6261)
• [UniProt: P21810](https://www.uniprot.org/uniprot/P21810)
• [Ensembl: ENSG00000196218](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000196218)
• [GeneCards: RYR1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=RYR1)
• [OMIM: 180901](https://www.omim.org/entry/180901)